A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Recruiting

Phase 1

Phase 2

IM-101A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Sponsor:

ImmunAbs Inc.

Code:

NCT07250750

Conditions

Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

IM-101 Part A

Placebo Part A

IM-101 Part B

Placebo Part B

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-11. This information was provided to ClinicalTrials.gov by ImmunAbs Inc. on 2026-02-11.